Clinical Laboratory Market Revenues to Reach USD 357.45 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
03 août 2023 09h30 HE
|
Mordor Intelligence
Hyderabad, Aug. 03, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “Clinical Laboratory Market Report (2023-2028),” the market is estimated at USD 261.02 billion in 2023....
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q’20 Guidance
13 janv. 2021 06h00 HE
|
Sian Capital, LLC
NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Sian Capital, LLC (together with its affiliates, “Sian” or “we”), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) (“OPKO” or the “Company”),...
Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From Many Patients Amidst COVID-19’s Second Wave
20 nov. 2020 16h45 HE
|
Sian Capital, LLC
Believes OPKO Should Promptly Distribute FDA-Reviewed Rayaldee to Help Treat COVID-19 in the U.S. and Europe Highlights the Opportunity Being Squandered by Dr. Frost and the Board as Europe...
Sian Capital Issues Open Letter to Stockholders of OPKO Health
12 nov. 2020 18h30 HE
|
Sian Capital, LLC
Highlights that Just Two Weeks after Sian Capital Sent Its 220 Demand Letter to OPKO, the Company has Agreed to Release A Subset of the Documents Requested, Which We Believe Will Validate our...
Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health
29 oct. 2020 17h20 HE
|
Sian Capital, LLC
Issues Presentation Outlining Viable Paths to Unlocking OPKO’s Intrinsic Value, Which is ~3x the Company’s Current Market Capitalization Based on its Diagnostic and Pharmaceutical Assets Releases...
TUESDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
09 nov. 2018 15h41 HE
|
Schall Law
LOS ANGELES, Nov. 09, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against OPKO Health, Inc. (“OPKO” or...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against OPKO Health, MGT Capital, and Applied Optoelectronics and Encourages Investors to Contact the Firm
06 nov. 2018 15h43 HE
|
Bragar Eagel & Squire
NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of OPKO Health, Inc., MGT...
November 13th Deadline in Lawsuit for investors in shares of OPKO Health, Inc. (NASDAQ: OPK) announced by Shareholders Foundation
06 nov. 2018 08h10 HE
|
Shareholders Foundation, Inc.
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a deadline is comping up on November 13th, 2018 in the lawsuit that was filed for certain investors in...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qurate, OPKO Health and Cocrystal and Encourages Investors to Contact the Firm
01 nov. 2018 21h46 HE
|
Bragar Eagel & Squire
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Qurate Retail Group, Inc.,...
IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against OPKO Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
29 oct. 2018 15h06 HE
|
Schall Law
LOS ANGELES, Oct. 29, 2018 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against OPKO Health, Inc. (“OPKO” or...